• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D 补充剂治疗急性呼吸道感染的疗效:一项随机对照试验的荟萃分析。

Efficacy of Vitamin D Supplements in Treatment of Acute Respiratory Infection: A Meta-Analysis for Randomized Controlled Trials.

机构信息

Department of Medicine, College of Medicine, Ewha Womans University, Seoul 07804, Korea.

Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Korea.

出版信息

Nutrients. 2022 Mar 8;14(6):1144. doi: 10.3390/nu14061144.

DOI:10.3390/nu14061144
PMID:35334804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8955452/
Abstract

BACKGROUND

Recent randomized controlled trials (RCTs) have reported inconsistent findings regarding the efficacy of vitamin D supplementation in the treatment of acute respiratory infections (ARIs). This study aimed to investigate the efficacy of vitamin D supplementation in the treatment of ARIs using a meta-analysis of RCTs.

METHODS

PubMed, EMBASE, and the Cochrane Library were searched for relevant articles in June 2021. Two of the authors independently assessed the eligibility of the trials.

RESULTS

Out of 390 articles retrieved from the databases, we included 18 RCTs, which involved 3648 participants, with 1838 in an intervention group and 1810 in a control group in the final analysis. In the meta-analysis of all the trials, vitamin D supplements had a beneficial effect in the treatment of ARIs (relative risk (RR) = 1.07; 95% confidence interval (CI), 1.01-1.13; I = 66.9%). Publication bias was observed in the funnel plot. In the subgroup meta-analysis of high-quality RCTs, no significant efficacy of vitamin D supplements was found (RR = 1.02; 95% CI, 0.98-1.06; I = 24.0%). Although statistically significant changes of 7% in the treatment effects were observed, they are not considered as clinically substantial ones.

CONCLUSIONS

The current meta-analysis suggests that vitamin D supplements are not clinically effective in the treatment of ARIs.

摘要

背景

最近的随机对照试验(RCT)报告了维生素 D 补充剂治疗急性呼吸道感染(ARI)的疗效不一致。本研究旨在通过 RCT 的荟萃分析来研究维生素 D 补充剂治疗 ARI 的疗效。

方法

2021 年 6 月,我们在 PubMed、EMBASE 和 Cochrane Library 中检索了相关文章。两位作者独立评估了试验的入选标准。

结果

从数据库中检索到 390 篇文章,我们纳入了 18 项 RCT,最终分析中共有 3648 名参与者,其中 1838 名在干预组,1810 名在对照组。在所有试验的荟萃分析中,维生素 D 补充剂对 ARI 的治疗有有益的影响(相对风险(RR)=1.07;95%置信区间(CI),1.01-1.13;I = 66.9%)。漏斗图显示存在发表偏倚。在高质量 RCT 的亚组荟萃分析中,未发现维生素 D 补充剂有显著疗效(RR = 1.02;95% CI,0.98-1.06;I = 24.0%)。虽然观察到治疗效果有 7%的统计学显著变化,但它们不被认为具有临床意义。

结论

目前的荟萃分析表明,维生素 D 补充剂在治疗 ARI 方面没有临床效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272a/8955452/a59c6ab9a378/nutrients-14-01144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272a/8955452/c31efa90a700/nutrients-14-01144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272a/8955452/384870e29164/nutrients-14-01144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272a/8955452/a59c6ab9a378/nutrients-14-01144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272a/8955452/c31efa90a700/nutrients-14-01144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272a/8955452/384870e29164/nutrients-14-01144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272a/8955452/a59c6ab9a378/nutrients-14-01144-g003.jpg

相似文献

1
Efficacy of Vitamin D Supplements in Treatment of Acute Respiratory Infection: A Meta-Analysis for Randomized Controlled Trials.维生素 D 补充剂治疗急性呼吸道感染的疗效:一项随机对照试验的荟萃分析。
Nutrients. 2022 Mar 8;14(6):1144. doi: 10.3390/nu14061144.
2
Efficacy of Vitamin D Supplements in Prevention of Acute Respiratory Infection: A Meta-Analysis for Randomized Controlled Trials.维生素 D 补充剂预防急性呼吸道感染的疗效:随机对照试验的荟萃分析。
Nutrients. 2022 Feb 15;14(4):818. doi: 10.3390/nu14040818.
3
Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials.维生素 D 补充剂预防急性呼吸道感染:随机对照试验汇总数据的系统评价和荟萃分析。
Lancet Diabetes Endocrinol. 2021 May;9(5):276-292. doi: 10.1016/S2213-8587(21)00051-6. Epub 2021 Mar 30.
4
Optimal methods of vitamin D supplementation to prevent acute respiratory infections: a systematic review, dose-response and pairwise meta-analysis of randomized controlled trials.维生素 D 补充预防急性呼吸道感染的最佳方法:系统评价、随机对照试验的剂量反应和成对荟萃分析。
Nutr J. 2024 Aug 14;23(1):92. doi: 10.1186/s12937-024-00990-w.
5
Vitamin D supplementation for prevention of acute respiratory infections in older adults: A systematic review and meta-analysis.维生素 D 补充剂预防老年人急性呼吸道感染:系统评价和荟萃分析。
PLoS One. 2024 May 24;19(5):e0303495. doi: 10.1371/journal.pone.0303495. eCollection 2024.
6
Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis.维生素 D 补充剂预防急性呼吸道感染:个体参与者数据荟萃分析。
Health Technol Assess. 2019 Jan;23(2):1-44. doi: 10.3310/hta23020.
7
Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis.间歇或单次大剂量维生素 D 补充对跌倒和骨折风险的影响:系统评价和荟萃分析。
Osteoporos Int. 2023 Aug;34(8):1355-1367. doi: 10.1007/s00198-023-06761-3. Epub 2023 Apr 29.
8
Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials.维生素和抗氧化补充剂预防心血管疾病的疗效:随机对照试验的系统评价和荟萃分析。
BMJ. 2013 Jan 18;346:f10. doi: 10.1136/bmj.f10.
9
Micronutrient supplementation in adults with HIV infection.对感染艾滋病毒的成年人进行微量营养素补充
Cochrane Database Syst Rev. 2017 May 18;5(5):CD003650. doi: 10.1002/14651858.CD003650.pub4.
10
Vitamin D supplementation and risk of respiratory tract infections: a meta-analysis of randomized controlled trials.维生素D补充剂与呼吸道感染风险:一项随机对照试验的荟萃分析
Scand J Infect Dis. 2013 Sep;45(9):696-702. doi: 10.3109/00365548.2013.803293. Epub 2013 Jul 2.

引用本文的文献

1
Vitamin D: A Nutraceutical Supplement at the Crossroad Between Respiratory Infections and COVID-19.维生素D:一种处于呼吸道感染和新冠肺炎交叉点的营养补充剂。
Int J Mol Sci. 2025 Mar 12;26(6):2550. doi: 10.3390/ijms26062550.
2
Silicosis: from pathogenesis to therapeutics.矽肺:从发病机制到治疗方法
Front Pharmacol. 2025 Jan 29;16:1516200. doi: 10.3389/fphar.2025.1516200. eCollection 2025.
3
Distinguishing science from pseudoscience in commercial respiratory interventions: an evidence-based guide for health and exercise professionals.

本文引用的文献

1
"Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis".“维生素 D 补充与 COVID-19 治疗:系统评价和荟萃分析”。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102189. doi: 10.1016/j.dsx.2021.102189. Epub 2021 Jun 28.
2
Vitamin D supplementation and improvement of pneumonic children at a tertiary pediatric hospital in Egypt: A randomized controlled trial.维生素 D 补充与埃及一所儿科三甲医院肺炎患儿改善的关系:一项随机对照试验。
Medicine (Baltimore). 2021 Apr 2;100(13):e25011. doi: 10.1097/MD.0000000000025011.
3
Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
区分商业呼吸干预措施中的科学与伪科学:健康和运动专业人员的循证指南。
Eur J Appl Physiol. 2023 Aug;123(8):1599-1625. doi: 10.1007/s00421-023-05166-8. Epub 2023 Mar 14.
一项随机临床试验:单次高剂量维生素 D3 对中重度 COVID-19 患者住院时间的影响。
JAMA. 2021 Mar 16;325(11):1053-1060. doi: 10.1001/jama.2020.26848.
4
Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis.维生素 D 补充剂、COVID-19 和疾病严重程度:一项荟萃分析。
QJM. 2021 May 19;114(3):175-181. doi: 10.1093/qjmed/hcab009.
5
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
6
Efficacy of High-Dose Vitamin D Supplementation as an Adjuvant Treatment on Pneumonia: Systematic Review and a Meta-Analysis of Randomized Controlled Studies.大剂量维生素 D 补充作为辅助治疗肺炎的疗效:系统评价和随机对照研究的荟萃分析。
Nutr Clin Pract. 2021 Apr;36(2):368-384. doi: 10.1002/ncp.10585. Epub 2020 Oct 9.
7
"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study"."骨化三醇治疗和最佳现有治疗与最佳现有治疗对因 COVID-19 住院患者入住重症监护病房和死亡的影响:一项前瞻性随机临床研究"。
J Steroid Biochem Mol Biol. 2020 Oct;203:105751. doi: 10.1016/j.jsbmb.2020.105751. Epub 2020 Aug 29.
8
The effects of anti-inflammatory agents as host-directed adjunct treatment of tuberculosis in humans: a systematic review and meta-analysis.抗炎症药物作为人类结核病宿主导向辅助治疗的效果:系统评价和荟萃分析。
Respir Res. 2020 Aug 26;21(1):223. doi: 10.1186/s12931-020-01488-9.
9
[Meta-analysis of efficacy and safety of vitamin D supplementation in the treatment of pulmonary tuberculosis].[维生素D补充剂治疗肺结核疗效与安全性的荟萃分析]
Zhonghua Yi Xue Za Zhi. 2020 Aug 25;100(32):2525-2531. doi: 10.3760/cma.j.cn112137-20200121-00146.
10
Oral Supplementation of the Vitamin D Metabolite 25(OH)D Against Influenza Virus Infection in Mice.口服补充维生素 D 代谢物 25(OH)D 可预防小鼠流感病毒感染。
Nutrients. 2020 Jul 5;12(7):2000. doi: 10.3390/nu12072000.